title: Psoriasis aggravation and metoprolol treatment -- a prospective observational case study.
authors.forename: R
authors.initials: R
authors.lastname: Fux
authors.forename: K
authors.initials: K
authors.lastname: Mörike
authors.forename: A M T
authors.initials: AM
authors.lastname: Pröhmer
authors.forename: U
authors.initials: U
authors.lastname: Delabar
authors.forename: E
authors.initials: E
authors.lastname: Schaeffeler
authors.forename: C H
authors.initials: CH
authors.lastname: Gleiter
authors.forename: M
authors.initials: M
authors.lastname: Schwab
mesh_terms: D000328:Adult; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011446:Prospective Studies; D011565:Psoriasis / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism
chemical_list: D003879:Dermatologic Agents; D019389:Cytochrome P-450 CYP2D6; D008790:Metoprolol